Victoza (Liraglutide) - the first GLP-1 analogue that started it all Medically reviewed by Dr Sultan Linjawi, Endocrinologist & Diabetes Specialist January 2026 Victoza (liraglutide) is a once-daily injectable medication used to treat type 2 diabetes
Presented for research literature review only Hughes S et al
If fasting glucose falls below 70 mg/dL on two or more occasions, contact the prescribing provider before continuing
Supp Care Cancer
Access to physician-supervised treatments Board-certified physician oversight Unlimited provider messaging Side effect management and protocol adjustments Progress tracking and check-ins Personalized dosing optimization Explore your treatment options A complete suite of physician-supervised therapies Options include NAD+, Glutathione, B12+MIC, L-Carnitine, and Sermorelin Flexible pricing, no insurance needed Real stories from real patients NAD+ as featured on Questions we hear every day Your first month is $109 for a full 30-day supply of pharmaceutical-grade Glutathione injections
In terms of clinical evidence, randomized clinical trials have shown that the GLP-1 receptor agonist exenatide may reduce alcohol consumption, particularly in individuals with co-occurring alcohol use disorder and obesity (Klausen et al., 2022)